Avenanthramides and Exercise

Exclusion Criteria

• •1. Presence of GI conditions that interfere with absorption;
• •2. Clinically significant endocrine, cardiovascular, pulmonary, renal, hepatic, pancreatic, biliary or neurologic disorders;
• •3. Major trauma or surgery within 3 months of visit;
• •4. Cancer in the prior 2 years;
• •5. Allergic to oat products;
• •6. Women who are pregnant or lactating;
• •7. Smoking;
• •8. Drinking alcohol \>5 drinks/week;
• •9. Using nutraceuticals;
• •10. Blood pressure medication;
• •11. NSAID (\>800 mg ibuprofen/week)
• •12. Vitamin supplementation
• •13. Anticoagulants or hypoglycemic drugs
• •14. Oat products consumption and rigorous physical activity the day before the test and consumption of a high-polyphenol diet in week prior to the test.
• •15. Moderate-intensity cardiorespiratory exercise training for ≥30 min•d-1 on ≥5 d•wk-1 for a total of ≥150 min•wk-1, vigorous-intensity cardiorespiratory exercise training for ≥20 min•d-1 on ≥3 d•wk-1 (≥75 min•wk-1), or a combination of moderate- and vigorous-intensity exercise to achieve a total energy expenditure of ≥500-1000 MET•min•wk-1